1,241 filings
Page 5 of 63
6-K
0ka4jwlwt 57
28 Jul 22
Condensed Half-year Consolidated Financial Statements
6:17am
6-K
pe1nfk wu1iws91tujs
20 Jul 22
Dupixent® (dupilumab) Phase 3 trial shows positive results in children 1 to 11 years of age with eosinophilic esophagitis
12:38pm
6-K
2dmtd2q 5m1h
13 Jul 22
Current report (foreign)
1:40pm
6-K
aep71hi
8 Jul 22
Sanofi Global Health launches nonprofit Impact® brand for 30 medicines in low-income countries
11:01am
6-K
zew8 xxukr7lz
30 Jun 22
Current report (foreign)
12:10pm
11-K
3rgs0
29 Jun 22
Annual report of employee stock purchases
11:48am
11-K
hcazso51plxg
29 Jun 22
Annual report of employee stock purchases
11:46am
6-K
q3thf pvj5
28 Jun 22
Sanofi-GSK first to report a successful efficacy study against Omicron with COVID-19 Beta-containing vaccine
3:59pm
6-K
o8qp52c
16 Jun 22
Sanofi-GSK next-generation COVID-19 booster delivers strong immune response against variants of concern, including Omicron
1:20pm
6-K
jewyc2
13 Jun 22
FDA approves Dupixent® (dupilumab) as first biologic medicine for children aged 6 months to 5 years with moderate-to-severe atopic dermatitis
2:56pm
6-K
tlsm9aa2 xa2e58ac
7 Jun 22
Current report (foreign)
2:51pm
6-K
aed5w m2h70
31 May 22
Update on Cialis® Rx-to-OTC Switch Actual Use Trial
10:56am
6-K
m9sce vh1cuh8hn0ltn
25 May 22
FDA approves Dupixent® (dupilumab) as first treatment for adults and children aged 12 and older with eosinophilic esophagitis
1:53pm
SD
0kikpfsurny3 7pjuu
25 May 22
Conflict minerals disclosure
10:10am
S-8
vm526v5aa4fhx40 h7ct
18 May 22
Registration of securities for employees
3:48pm
6-K
bp45cw2yr53qwwu8
17 May 22
Current report (foreign)
3:20pm
S-8 POS
3tk0w3
17 May 22
Registration of securities for employees (post-effective amendment)
8:42am
6-K
f3o93
16 May 22
IFRS net sales reported
1:45pm
6-K
mxn22iob02 cp15sxv7l
9 May 22
Approval of the financial statements for the fiscal year 2021
2:29pm
6-K
j242ofdlqyp
29 Apr 22
Current report (foreign)
12:38pm